GSK PLC on Wednesday restructured an existing collaboration with CureVac NV into a new licensing agreement to take co ...
GSK PLC 03 July 2024 Issued: 3 July 2024, London UK; Tübingen, Germany/ Boston, MA, USA GSK and CureVac to restructure collaboration into...
GSK PLC 01 July 2024 GSK plc Total Voting Rights and Capital In conformity with the Financial Conduct Authority's Disclosure Guidance and...
based pharmaceuticals company - Reaches confidential settlement with Martin Gross resolving the case he filed in Illin ...
GSK PLC 28 June 2024 Issued: 28 June 2024, London UK Statement: Zantac (ranitidine) litigation - Gross case GSK plc (LSE/NYSE: GSK) has...
GSK PLC on Monday said it has landed an approval in Japan and also highlighted regulatory progress in the EU. The B ...
GSK PLC 24 June 2024 Issued: 24 June 2024, London UK GSK's Omjjara (momelotinib) approved in Japan for treatment of myelofibrosis · ...
GSK PLC 24 June 2024 Issued: 24 June 2024, London UK Jemperli (dostarlimab) plus chemotherapy application accepted for review by the...
GSK PLC 21 June 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a...
GSK PLC 12 June 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a...
GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in reg ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.